Literature DB >> 20307592

Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.

Caterina Rizzo1, Maria Cristina Rota, Antonino Bella, Valeria Alfonsi, Silvia Declich, Maria Grazia Caporali, Alessia Ranghiasci, Giulia Lapini, Simona Piccirella, Stefania Salmaso, Emanuele Montomoli.   

Abstract

To assess in Italy the pre-pandemic susceptibility of the general population to the 2009 A/H1N1v influenza virus, 587 serum samples collected in 2004 were analyzed using haemagglutination-inhibition (HI), single-radial-haemolysis (SRH) and microneutralisation (MN) assays. Serum samples were stratified by age group, gender, and geographic area. Overall, using HI assay, the proportion of subjects showing antibodies cross-reacting with 2009 A/H1N1v virus at seroprotection level (>or=1:40) was estimated to be 6.7%, 12.4%, and 22.4% in individuals born between 2004 and 1949, 1948 and 1939, 1938 and 1909, respectively. With a HI antibody titre of >or=1:10, in the same birth cohort, the seroprotection levels were 13.5%, 19.2%, and 58.2%, respectively. The results suggest that the Italian population was not fully naïf to the current pandemic virus and that the possible previous exposure and immune response increases with age. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307592     DOI: 10.1016/j.vaccine.2010.03.006

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  45 in total

1.  Retrospective investigation of an influenza A/H1N1pdm outbreak in an Italian military ship cruising in the Mediterranean Sea, May-September 2009.

Authors:  Mario Tarabbo; Daniele Lapa; Concetta Castilletti; Pietro Tommaselli; Riccardo Guarducci; Giuditta Lucà; Alessandro Emanuele; Onofrio Zaccaria; Vincenzo F P La Gioia; Enrico Girardi; Maria R Capobianchi; Giuseppe Ippolito
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

2.  Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Authors:  Danuta M Skowronski; Travis S Hottes; Janet E McElhaney; Naveed Z Janjua; Suzana Sabaiduc; Tracy Chan; Beth Gentleman; Dale Purych; Jennifer Gardy; David M Patrick; Robert C Brunham; Gaston De Serres; Martin Petric
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

Review 3.  Seroprevalence to influenza A(H1N1) 2009 virus--where are we?

Authors:  Eeva Broberg; Angus Nicoll; Andrew Amato-Gauci
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

4.  Seroprevalence of antibodies to influenza A/H1N1/2009 among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method.

Authors:  Leticia Elizondo-Montemayor; Mario M Alvarez; Martín Hernández-Torre; Patricia A Ugalde-Casas; Lorena Lam-Franco; Humberto Bustamante-Careaga; Fernando Castilleja-Leal; Julio Contreras-Castillo; Héctor Moreno-Sánchez; Daniela Tamargo-Barrera; Felipe López-Pacheco; Pamela J Freiden; Stacey Schultz-Cherry
Journal:  Int J Infect Dis       Date:  2011-08-19       Impact factor: 3.623

5.  CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses.

Authors:  Kristin Scheible; Gang Zhang; Jane Baer; Mitra Azadniv; Kris Lambert; Gloria Pryhuber; John J Treanor; David J Topham
Journal:  Vaccine       Date:  2011-01-04       Impact factor: 3.641

6.  Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.

Authors:  Vic Veguilla; Kathy Hancock; Jarad Schiffer; Paul Gargiullo; Xiuhua Lu; Darbi Aranio; Alicia Branch; Libo Dong; Crystal Holiday; Feng Liu; Evelene Steward-Clark; Hong Sun; Byron Tsang; David Wang; Melissa Whaley; Yaohui Bai; Li Cronin; Peter Browning; Hanan Dababneh; Heather Noland; Leilani Thomas; Lydia Foster; Conrad P Quinn; Stephen D Soroka; Jacqueline M Katz
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

Review 7.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

8.  Seroprevalence study of antibodies against influenza A(H1N1) 2009 virus after the second pandemic wave in Slovenia.

Authors:  Vesna Subelj; Katarina Prosenc; Maja Sočan
Journal:  Wien Klin Wochenschr       Date:  2012-02-15       Impact factor: 1.704

9.  A new approach to characterising infectious disease transmission dynamics from sentinel surveillance: application to the Italian 2009-2010 A/H1N1 influenza pandemic.

Authors:  Ilaria Dorigatti; Simon Cauchemez; Andrea Pugliese; Neil Morris Ferguson
Journal:  Epidemics       Date:  2011-11-28       Impact factor: 4.396

10.  Searching for sharp drops in the incidence of pandemic A/H1N1 influenza by single year of age.

Authors:  Jessica Hartman Jacobs; Brett Nicholas Archer; Michael G Baker; Benjamin J Cowling; Richard T Heffernan; Geoff Mercer; Osvaldo Uez; Wanna Hanshaoworakul; Cécile Viboud; Joel Schwartz; Eric Tchetgen Tchetgen; Marc Lipsitch
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.